Opioid Crisis

Supporting the mission and goals of National Fentanyl Awareness Day in 2025, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.

The resolution increases public-health attention, awareness, and justification for enforcement against deadly counterfeit fentanyl pills—potentially reducing youth overdoses—but may shift resources toward policing, further stigmatize people who use drugs, and raise compliance costs for online commerce.

Strengthening Sanctions on Fentanyl Traffickers Act of 2025

The bill strengthens U.S. tools to disrupt international synthetic-drug supply chains and gives law enforcement and financial actors clearer authority to block illicit flows, but it broadens reach and liability, raises compliance costs, and risks diplomatic and due-process consequences that could strain trade and complicate enforcement.

Expressing support for the designation of February 23, 2025, to March 1, 2025, as "National Fentanyl Awareness Week" and raising awareness of the negative impacts of fentanyl in the United States.

The resolution raises important awareness and data-driven responses to the deadly rise of fentanyl—likely improving prevention, naloxone access, and law-enforcement/public-health coordination—but risks steering policy and funding toward enforcement and alarm-driven, punitive responses instead of expanded treatment and harm-reduction.

SAFE Act

The bill sharpens and speeds federal control and enforcement against fentanyl-related substances and creates scientific and procedural pathways for rescheduling and research, but it risks criminalizing legitimate research and low-level handlers, increases mandatory penalties that can widen disparities and incarceration costs, and could leave enforcement gaps for new synthetic opioids.